Advanced in IgG4-Related Disease

Mohamed A. Hamidou

CHU De Poitiers
Poitiers, FR 
Clinical Trials:Currently Recruiting for 1 Trial

Advanced in IgG4-Related Disease
CHU De Poitiers
Poitiers, FR 
OverviewLocationsClinical Research

Overview

Mohamed Hamidou practices in Poitiers, France. Mr. Hamidou is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Vasculitis, Necrotizing Vasculitis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and Splenectomy.

His clinical research consists of co-authoring 195 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of IgG4-Related Disease.

Gender
Male

Locations

CHU de Poitiers
Poitiers, France
Other Locations
CH
Valenciennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
Enrollment Status: Recruiting
Publish Date: April 30, 2025
Intervention Type: Drug
Study Drug: BLU-263
Study Phase: Phase 2/Phase 3
Restauration of EBV Control in SLE Phase 1-2 Trial Evaluating Adoptive Transfer of Autologous EBV- Specific Cytotoxic T Lymphocytes in SLE Treatment
Restauration of EBV Control in SLE Phase 1-2 Trial Evaluating Adoptive Transfer of Autologous EBV- Specific Cytotoxic T Lymphocytes in SLE Treatment
Enrollment Status: Terminated
Publish Date: March 25, 2022
Intervention Type: Biological
Study Drug: Autologous EBV specific CTL infusion
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

195 Total Publications

Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study).
Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study).
Journal: Rheumatology international
Published: February 17, 2024
View All 195 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hamidou's expertise for a condition
ConditionClose
  • Elite
  • Necrotizing Vasculitis
    Mr. Hamidou is
    Elite
    . Learn about Necrotizing Vasculitis.
    See more Necrotizing Vasculitis experts
  • Vasculitis
    Mr. Hamidou is
    Elite
    . Learn about Vasculitis.
    See more Vasculitis experts
  • Distinguished
  • Granulomatosis with Polyangiitis
    Mr. Hamidou is
    Distinguished
    . Learn about Granulomatosis with Polyangiitis.
    See more Granulomatosis with Polyangiitis experts
  • Immune Thrombocytopenic Purpura (ITP)
    Mr. Hamidou is
    Distinguished
    . Learn about Immune Thrombocytopenic Purpura (ITP).
    See more Immune Thrombocytopenic Purpura (ITP) experts
  • Microscopic Polyangiitis
    Mr. Hamidou is
    Distinguished
    . Learn about Microscopic Polyangiitis.
    See more Microscopic Polyangiitis experts
  • Purpura
    Mr. Hamidou is
    Distinguished
    . Learn about Purpura.
    See more Purpura experts
  • Thrombocytopenia
    Mr. Hamidou is
    Distinguished
    . Learn about Thrombocytopenia.
    See more Thrombocytopenia experts
  • Advanced
  • Acute Interstitial Pneumonia
    Mr. Hamidou is
    Advanced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Adult Immune Thrombocytopenia
    Mr. Hamidou is
    Advanced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Adult Still's Disease
    Mr. Hamidou is
    Advanced
    . Learn about Adult Still's Disease.
    See more Adult Still's Disease experts
  • Autoimmune Hemolytic Anemia
    Mr. Hamidou is
    Advanced
    . Learn about Autoimmune Hemolytic Anemia.
    See more Autoimmune Hemolytic Anemia experts
  • Blood Clots
    Mr. Hamidou is
    Advanced
    . Learn about Blood Clots.
    See more Blood Clots experts
  • Cogan's Syndrome
    Mr. Hamidou is
    Advanced
    . Learn about Cogan's Syndrome.
    See more Cogan's Syndrome experts
View All 27 Advanced Conditions
  • Experienced
  • Acute Pain
    Mr. Hamidou is
    Experienced
    . Learn about Acute Pain.
    See more Acute Pain experts
  • ADULT Syndrome
    Mr. Hamidou is
    Experienced
    . Learn about ADULT Syndrome.
    See more ADULT Syndrome experts
  • Adult T-Cell Leukemia
    Mr. Hamidou is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Agranulocytosis
    Mr. Hamidou is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anemia
    Mr. Hamidou is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Antiphospholipid Syndrome
    Mr. Hamidou is
    Experienced
    . Learn about Antiphospholipid Syndrome.
    See more Antiphospholipid Syndrome experts
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved